Aspire Biopharma Holdings Inc.(ASBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ASBP Aspire Biopharma Holdings Inc.

Closed 06-25 16:00:00 EDT

6.46

-0.08

-1.30%

盘后6.20

-0.25-3.95%

19:06 EDT

High6.59	Low6.19	Vol70.21K
Open6.48	D1 Closing6.54	Amplitude6.06%
Mkt Cap8.36M	Tradable Cap659.70K	Total Shares1.30M
T/O449.17K	T/O Rate68.70%	Tradable Shares102.20K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ASBP","market":"US","secType":"STK","nameCN":"Aspire Biopharma Holdings Inc.","latestPrice":6.455,"timestamp":1782417600000,"preClose":6.54,"halted":0,"volume":70212,"hourTrading":{"tag":"盘后","latestPrice":6.2,"preClose":6.455,"latestTime":"19:06 EDT","volume":2006,"amount":12904.042,"timestamp":1782428818876,"change":-0.255,"changeRate":-0.039504,"amplitude":0.052719},"delay":0,"changeRate":-0.01299694189602446,"floatShares":102200,"shares":1295200,"eps":-153.5649,"marketStatus":"Closed","change":-0.085,"latestTime":"06-25 16:00:00 EDT","open":6.48,"high":6.5866,"low":6.19,"amount":449166.38505599997,"amplitude":0.060642,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-153.5649,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782460800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":6.54,"preHourTrading":{"tag":"盘前","latestPrice":6.3889,"preClose":6.54,"latestTime":"09:15 EDT","volume":2079,"amount":13129.5305295,"timestamp":1782393331081,"change":-0.1511,"changeRate":-0.023104,"amplitude":0.039174},"postHourTrading":{"tag":"盘后","latestPrice":6.2,"preClose":6.455,"latestTime":"19:06 EDT","volume":2006,"amount":12904.042,"timestamp":1782428818876,"change":-0.255,"changeRate":-0.039504,"amplitude":0.052719},"volumeRatio":0.493973},"requestUrl":"/m/hq/s/ASBP/wiki","defaultTab":"wiki","newsList":[{"id":"2645282818","title":"Aspire Unit Buzz Bomb Caffeine Launches BUZZ BOMB 50 Mg Caffeine Stick Packs on Amazon","url":"https://stock-news.laohu8.com/highlight/detail?id=2645282818","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645282818?lang=en_us&edition=fundamental","pubTime":"2026-06-24 20:30","pubTimestamp":1782304252,"startTime":"0","endTime":"0","summary":"Aspire unit Buzz Bomb Caffeine launches BUZZ BOMB 50 mg caffeine stick packs on AmazonAspire Biopharma’s wholly owned unit Buzz Bomb Caffeine Company launched BUZZ BOMB 50 mg caffeine stick packs on A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL25KP4p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645837663","title":"Aspire Biopharma posts investor deck on sublingual drug-delivery platform, lead sublingual aspirin program","url":"https://stock-news.laohu8.com/highlight/detail?id=2645837663","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645837663?lang=en_us&edition=fundamental","pubTime":"2026-06-23 22:59","pubTimestamp":1782226749,"startTime":"0","endTime":"0","summary":"Aspire Biopharma outlined plans to acquire Dura Driver Control Systems for USD 30 million in cash, adding a business with 2025 revenue above USD 200 million.Dura reported 2025 net income above USD 17 million, adjusted EBITDA above USD 22 million, operations across 11 facilities, portfolio of 310+ patents.Lead prescription program OTASA 162 mg sublingual aspirin completed a July 2025 trial, showing therapeutic exposure at least five times faster than chewed tablets.FDA feedback supports a 505 filing in Q1 2027; IND planned for September; 32-subject crossover trial targeted for completion by end-2026.Consumer product BUZZ BOMB caffeine launched in Q3 2025; 50 mg sublingual powder format; distribution agreements cited with Amazon, TruLife, Interwest Brokerage.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL88kvTZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645390468","title":"Aspire Biopharma to present at Life Sciences Virtual Investor Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2645390468","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645390468?lang=en_us&edition=fundamental","pubTime":"2026-06-23 21:07","pubTimestamp":1782220054,"startTime":"0","endTime":"0","summary":"Aspire Biopharma will participate in the Life Sciences Virtual Investor Forum on June 24-25, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief on June 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL8TlXnr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645070611","title":"Aspire Biopharma stockholders approve warrant share issuance proposal at special meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2645070611","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645070611?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:36","pubTimestamp":1782160581,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings held a special shareholder meeting on June 16, 2026.Shareholders authorized issuance of common stock upon exercise of warrants, including shares above the 19.99% threshold, at an exercise price of $0.00001 per share.Investors also endorsed an adjustment to the number of common shares issuable upon exercise of the warrants under the warrant agreement with the company’s financial advisor.Shareholders approved voluntary adjustments to the warrants’ exercise price under the terms of the warrant.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL438gyY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644742408","title":"Aspire Biopharma to present at Life Sciences Investor Forum hosted by VirtualInvestorConferences.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2644742408","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644742408?lang=en_us&edition=fundamental","pubTime":"2026-06-17 22:58","pubTimestamp":1781708282,"startTime":"0","endTime":"0","summary":"Aspire Biopharma will present at the Life Sciences Investor Forum on June 25, 2026.The online presentation is scheduled for 2:00 p.m. ET.Management will be available for one-on-one meetings June 24-25, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL3smnYj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU2210150020.SGD","BK4585","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4007","IE00BKPKM429.USD","IE00BN0W2W23.USD","BK4588","SG9999014005.SGD","BK4112","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","NDAQ","SG9999014021.USD","IE00BGHQF748.EUR","LU2210149790.SGD","LU0314104364.USD","ASBP","LU2095319765.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643183213","title":"Aspire Biopharma delays shareholder meeting to June 16 after lacking quorum","url":"https://stock-news.laohu8.com/highlight/detail?id=2643183213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643183213?lang=en_us&edition=fundamental","pubTime":"2026-06-13 05:16","pubTimestamp":1781298985,"startTime":"0","endTime":"0","summary":"Aspire Biopharma adjourned its June 9, 2026 shareholder meeting due to lack of quorum.The meeting was rescheduled for June 16 at 10:00 a.m. EST.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL9XLtJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643429783","title":"Aspire Biopharma Holdings Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2643429783","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643429783?lang=en_us&edition=fundamental","pubTime":"2026-06-13 02:10","pubTimestamp":1781287838,"startTime":"0","endTime":"0","summary":"14:07 EDT Aspire Biopharma (ASBP) Holdings Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-ti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-holdings-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-holdings-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643292761","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2643292761","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643292761?lang=en_us&edition=fundamental","pubTime":"2026-06-13 02:01","pubTimestamp":1781287309,"startTime":"0","endTime":"0","summary":"Adobe's  CFO departure and fiscal 2026 organic annual recurring revenue outlook have created more uncertainty for the company, outweighing its fiscal Q2 results, RBC Capital Markets said in a note emailed Friday.Shares of Adobe dropped 7%, with intraday trading volume rising to more than 19.0 million from the stock's daily average of about 5.71 million.Aspire Biopharma  agreed to acquire Dura Driver Control Systems, a manufacturer of automotive driver control systems, for $30 million in cash, according to a statement on Friday.Shares slumped 19%. Intraday trading volume stood at more than 10.0 million, versus a daily average of about 13.1 million.Price: 201.17, Change: -17.63, Percent Change: -8.06","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4534","LU1674673691.USD","IE00B19Z9505.USD","LU1712237335.SGD","BK4567","SG9999001424.SGD","BK4023","ADBG","LU0109391861.USD","LU0889566641.SGD","LU0082616367.USD","LU0289961442.SGD","LU0719512351.SGD","LU0965509283.SGD","LU0342679015.USD","IE00BYQQ9H92.USD","LU1267930730.SGD","LU0061474960.USD","BK4554","BK4592","LU0069063385.USD","LU0157215616.USD","LU1623119135.USD","LU1267930813.SGD","LU1823568750.SGD","LU0345774391.USD","IE00BQXX3D17.EUR","LU0057025933.USD","SGXZ51526630.SGD","LU0511384066.AUD","LU2237438978.USD","LU0792757196.USD","LU0348723411.USD","IE00B5TLWC47.USD","BK4585","LU0557290698.USD","LU1261432733.SGD","LU1366333091.USD","LU0198837287.USD","LU2360032135.SGD","LU2210150020.SGD","SG9999000418.SGD","LU0109392836.USD","LU2210149790.SGD","LU0708995401.HKD","BK4543","SGXZ99366536.SGD","LU0889565833.HKD","BK4527","LU0234570918.USD","LU1548497426.USD","LU2458330169.SGD","LU2236285917.USD","LU0472753341.HKD","BK4533","LU0289739343.SGD","LU0957791311.USD","IE00BQXX3F31.USD","LU2095319765.USD","IE00BQXX3C00.GBP","LU0006306889.USD","BK4581","LU0345774631.USD","LU1084165304.USD","LU2458330243.SGD","LU0672654240.SGD","LU0942090050.USD","LU1720051108.HKD","LU2023251221.USD","LU0081259029.USD","LU0320765059.SGD","LU1803068979.SGD","BK4566","BK4007","LU2089283258.USD","IE0009356076.USD","ADBE","LU1674673428.USD","LU2089284900.SGD","SGXZ81514606.USD","BK4528","LU1691799644.USD","ASBP","LU0170899867.USD","LU1778281490.HKD","LU0868494708.USD","LU2125154778.USD","BK4588","LU2125154935.USD","LU0106261372.USD","LU1815333072.USD","LU0314104364.USD","LU1633808545.USD","LU0861579265.USD","LU2317271919.USD","LU0234572021.USD","IE00BFXG0V08.USD","LU0158827948.USD","LU0965509101.SGD","LU2357305700.SGD","LU1119994496.HKD","LU1046421795.USD","LU1720051017.SGD","LU0965509010.AUD","LU1235294995.USD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642877299","title":"Press Release: Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2642877299","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642877299?lang=en_us&edition=fundamental","pubTime":"2026-06-12 22:33","pubTimestamp":1781274780,"startTime":"0","endTime":"0","summary":"-- Adds an established global brand with scale in large and growing markets. driven by trends in vehicle and mobility control systems. -- Acquisition significantly accelerates Aspire's revenue, earnings growth. -- Opportunity to drive significant shareholder value creation and enhance. -- Company does not anticipate procuring new equity financing to consummate. ESTERO, FL / ACCESS Newswire / June 12, 2026 / Aspire Biopharma Holdings,signing of a definitive Share Purchase Agreement  for the. acquisition of 100% of Dura Driver Control Systems , a premier. designer and manufacturer of automotive driver control systems with. The proposed acquisition represents a transformative milestone for. Aspire, positioning the Company to rapidly evolve into a diversified,\"We are thrilled to welcome the DCS team into Aspire and to build a. said Kraig Higginson, Interim CEO and Chairperson of the Aspire. Biopharma Board. \"Our acquisition of DCS, an established global. Pursuant to the terms of the SPA, A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642296701","title":"Aspire Biopharma - Enters Purchase Agreement With Firefish Topco on June 10, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2642296701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642296701?lang=en_us&edition=fundamental","pubTime":"2026-06-12 22:28","pubTimestamp":1781274497,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K080:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642296065","title":"Aspire Biopharma - to Pay $30 Mln Plus $800,000 Deferred Revenue as Purchase Price - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2642296065","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642296065?lang=en_us&edition=fundamental","pubTime":"2026-06-12 22:28","pubTimestamp":1781274497,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K080:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642129826","title":"Aspire Biopharma signs agreement to buy Dura Driver Control Systems for $30 million cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2642129826","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642129826?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:30","pubTimestamp":1781267457,"startTime":"0","endTime":"0","summary":"Aspire Biopharma signed a definitive share purchase agreement to buy Dura Driver Control Systems for USD 30 million cash.Target posted FY2025 unaudited revenue above USD 200 million, net income above USD 17 million, adjusted EBITDA above USD 22 million.Deal expected to close in Q3 2026, subject to customary closing conditions.Dura Driver Control Systems will become a wholly owned subsidiary; CEO Hans Vorstenbosch is set to remain in charge.Buyer indicated it does not anticipate raising new equity to complete the acquisition.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL1gNmQy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639697851","title":"Aspire Biopharma issues letter to shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2639697851","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639697851?lang=en_us&edition=fundamental","pubTime":"2026-05-28 23:44","pubTimestamp":1779983079,"startTime":"0","endTime":"0","summary":"Aspire Biopharma (ASBP) issued the following letter to shareholders from Chief Executive Officer Kraig Higginson. “2026 is shaping up to be a defin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-issues-letter-to-shareholders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-issues-letter-to-shareholders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638934866","title":"Aspire Biopharma issues shareholder letter to investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2638934866","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638934866?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:30","pubTimestamp":1779971444,"startTime":"0","endTime":"0","summary":"Aspire Biopharma posted a shareholder letter from CEO Kraig Higginson outlining 2026 priorities across drug delivery development, consumer supplements, capital actions.Board authorized a USD 5 million share repurchase program; letter cited about USD 21 million net proceeds from a preferred stock private placement.Lead high-dose sublingual aspirin program targeted an NDA filing via the 505 pathway by end-2026; letter also referenced broader patent filings.Binding LOI disclosed April 16, 2026 to buy Dura Driver Control Systems for USD 30 million cash; letter cited 2025 revenue over USD 200 million, Adjusted EBITDA over USD 22 million.Letter stated the DCS deal has a USD 22.5 million financing commitment, not expected to require a new equity raise; link.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL4sQ68L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638500244","title":"Aspire Biopharma unit Buzz Bomb Caffeine partners with EoS Fitness affiliate program","url":"https://stock-news.laohu8.com/highlight/detail?id=2638500244","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638500244?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:30","pubTimestamp":1779885044,"startTime":"0","endTime":"0","summary":"Aspire Biopharma’s wholly owned Buzz Bomb Caffeine unit partnered with HVLP gym chain EoS Fitness via its Flex Deals affiliate program.BUZZ BOMB 50mg sublingual caffeine stick packs will be marketed to EoS members across more than 225 locations open or planned nationwide.Distribution will run through in-gym TV advertising, mobile app offers, on-site product demonstrations, member communications.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL7TLp5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635559480","title":"Aspire Biopharma Hldgs Q1 EPS $(20.57) Up From $(504.88) YoY, Sales $28.353K","url":"https://stock-news.laohu8.com/highlight/detail?id=2635559480","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635559480?lang=en_us&edition=fundamental","pubTime":"2026-05-16 06:47","pubTimestamp":1778885251,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(20.57) per share. This is a 95.93 percent increase over losses of $(504.88) per share from the same period last year.  The company reported $28.353","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52620581/aspire-biopharma-hldgs-q1-eps-20-57-up-from-504-88-yoy-sales-28-353k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Aspire Biopharma Hldgs Q1 EPS $(20.57) Up From $(504.88) YoY, Sales $28.353K","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635305030","title":"Aspire Biopharma Q1 FY26 net loss narrows to 3.22 million; revenue rises to 28,353","url":"https://stock-news.laohu8.com/highlight/detail?id=2635305030","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635305030?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:26","pubTimestamp":1778876770,"startTime":"0","endTime":"0","summary":"Aspire Biopharma posted a net loss of USD 3.22 million for the quarter ended March 31, 2026, narrowing from a net loss of USD 15.94 million a year earlier.Operating loss narrowed to USD 1.65 million from USD 15.56 million, while general and administrative expense fell to USD 1.02 million from USD 15.07 million.Revenue was USD 28,353, with cost of revenue of USD 22,603.Cash was USD 5.86 million at March 31, 2026; management said liquidity is sufficient to fund operations for at least one year after filing, with an additional USD 9 million received in April 2026 from the final tranche of a Series A Convertible Preferred Stock financing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL3WRm21:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634149398","title":"Aspire Biopharma Holdings Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2634149398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634149398?lang=en_us&edition=fundamental","pubTime":"2026-05-09 07:50","pubTimestamp":1778284215,"startTime":"0","endTime":"0","summary":"19:50 EDT Aspire Biopharma (ASBP) Holdings Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-holdings-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-holdings-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633129396","title":"Aspire Biopharma effects 1-for-30 reverse stock split May 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2633129396","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633129396?lang=en_us&edition=fundamental","pubTime":"2026-05-07 23:03","pubTimestamp":1778166208,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings will execute a 1-for-30 reverse stock split effective May 11, 2026, before Nasdaq trading opens.Shares will trade on a post-split basis under existing ticker ASBP.Move targets compliance with Nasdaq minimum bid price requirement.Reverse split expected to cut shares outstanding to about 1,210,983 from about 36,329,490.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL8ykBDg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630997603","title":"Aspire Biopharma launches USD 5 million share buyback program","url":"https://stock-news.laohu8.com/highlight/detail?id=2630997603","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630997603?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:31","pubTimestamp":1777293114,"startTime":"0","endTime":"0","summary":"Aspire Biopharma authorized a share repurchase program of up to USD 5 million.Buybacks may be executed through open-market purchases or privately negotiated transactions.Funding expected to come from existing cash on hand.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL1c82Rq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aspirebiolabs.com","stockEarnings":[{"period":"1week","weight":0.0283},{"period":"1month","weight":0.2089},{"period":"3month","weight":-0.7604},{"period":"6month","weight":-0.9495},{"period":"1year","weight":-0.98},{"period":"ytd","weight":-0.9587}],"compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":-0.0166},{"period":"3month","weight":0.1366},{"period":"6month","weight":0.0622},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0753}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PowerUp Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on video gaming, gaming adjacent, and metaverse businesses. PowerUp Acquisition Corp. was incorporated in 2021 and is based in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":-0.11488},{"month":2,"riseRate":0.5,"avgChangeRate":-0.30463},{"month":3,"riseRate":0.25,"avgChangeRate":-0.216086},{"month":4,"riseRate":0.5,"avgChangeRate":-0.260922},{"month":5,"riseRate":0.4,"avgChangeRate":-0.032731},{"month":6,"riseRate":0.8,"avgChangeRate":-0.035318},{"month":7,"riseRate":0.75,"avgChangeRate":0.106788},{"month":8,"riseRate":0.75,"avgChangeRate":0.136896},{"month":9,"riseRate":0.5,"avgChangeRate":-0.137877},{"month":10,"riseRate":0.75,"avgChangeRate":0.199866},{"month":11,"riseRate":0.5,"avgChangeRate":-0.177747},{"month":12,"riseRate":1,"avgChangeRate":0.063987}],"exchange":"NASDAQ","name":"Aspire Biopharma Holdings Inc.","nameEN":"Aspire Biopharma Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aspire Biopharma Holdings Inc.(ASBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aspire Biopharma Holdings Inc.(ASBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aspire Biopharma Holdings Inc.,ASBP,Aspire Biopharma Holdings Inc.股票,Aspire Biopharma Holdings Inc.股票老虎,Aspire Biopharma Holdings Inc.股票老虎国际,Aspire Biopharma Holdings Inc.行情,Aspire Biopharma Holdings Inc.股票行情,Aspire Biopharma Holdings Inc.股价,Aspire Biopharma Holdings Inc.股市,Aspire Biopharma Holdings Inc.股票价格,Aspire Biopharma Holdings Inc.股票交易,Aspire Biopharma Holdings Inc.股票购买,Aspire Biopharma Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aspire Biopharma Holdings Inc.(ASBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aspire Biopharma Holdings Inc.(ASBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction